Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial
Open Access
- 10 June 2021
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 21 (1) , 1-12
Abstract
Background: We aimed to evaluate the effects of different therapeutic options to prevent the evolution of vaginal stenosis after pelvic radiotherapy in women with cervical cancer. Methods: open-label randomized clinical trial of 195 women, stage I-IIIB, aged 18–75 years, using topical estrogen (66), topical testosterone (34), water-based intimate lubricant gel (66), and vaginal dilators (29) to assess the incidence and severity of vaginal stenosis after radiotherapy at UNICAMP-Brazil, from January/2013 to May/2018. The main outcome measure was vaginal stenosis assessed using the Common Terminology Criteria for Adverse Events (CTCAE) scale and percental changes in vaginal volume. The women were evaluated at four different times: shortly after the end of radiotherapy, and four, eight, and 12 months after the beginning of the intervention. Statistical analysis was carried out using Symmetry test, Kruskal-Wallis test and multiple regression. Results: the mean age of women was 46.78 (±13.01) years, 61,03% were premenopausal and 73,84% had stage IIB-IIIB tumors. The mean reduction in vaginal volume in the total group was 25.47%, with similar worsening in the four treatment groups with no statistical difference throughout the intervention period. There was worsening of vaginal stenosis evaluated by CTCAE scale after 1 year in all groups (p < 0.01), except for the users of vaginal dilator (p = 0.37). Conclusions: there was a reduction in vaginal volume in all treatment groups analyzed, with no significant difference between them. However, women who used vaginal dilators had a lower frequency and severity of vaginal stenosis assessed by the CTCAE scale after one year of treatment. Trial registration: Brazilian Registry of Clinical Trials, RBR-23w5fv. Registered 10 January 2017 - Retrospectively registered.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2012/09215-7)
This publication has 35 references indexed in Scilit:
- Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine CervixJAMA Oncology, 2018
- Radiation-induced vaginal stenosis: current perspectivesInternational Journal of Women's Health, 2017
- Sexual function and quality of life in women with cervical cancer before radiotherapy: a pilot studyArchives of Gynecology and Obstetrics, 2015
- Longitudinal Analysis of Late Vaginal Mucosal Reactions After High-dose-rate Brachytherapy in Patients with Gynecological Cancer2014
- Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopauseClimacteric, 2014
- Management of symptomatic vulvovaginal atrophyMenopause, 2013
- Topical Testosterone for Breast Cancer Patients with Vaginal Atrophy Related to Aromatase Inhibitors: A Phase I/II StudyThe Oncologist, 2011
- Serum estrogen and androgen levels following treatment for cervical cancer.1994
- Sexual dysfunction after therapy for cervical carcinomaAmerican Journal of Obstetrics and Gynecology, 1974
- Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteriCancer, 1972